Virus inactivation in the 1990s - And into the 21st century: Part 1: Skin, bone, and cells

BioPharm

Volumn 15, Issue 7, 2002, Pages 18-24

  Sofer, Gail ^a  

^a BioReliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

BIOMEDICINE; BONE; CELL; DISINFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; REVIEW; SKIN; VIRUS INACTIVATION;

EID: 0036663571     PISSN: 10408304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. P.U. Cameron et al., "Efficacy and kinetics of glycerol inactivation of HIV-1 in split skin grafts," J. Med. Virol. 60(2), 182-188 (2000).
2. A.C. de Backere, "Euro skin bank: Large-Scale skin-banking in Europe based on glycerol preservation of donor skin," Burns 20(1), S4-S9 (1994).
3. L. Marshall et al., "Effect of glycerol on intracellular virus survival: Implications for the clinical use of glycerol-preserved cadaver skin," Burns 21(5), 356-361 (1995).
4. M.M. Ghosh and E. Freedlander, "Inactivation of viruses by glycerol as used in allograft skin preservation" (letter, comment), Burns 20(5), 476-477 (1994).
5. J. Van Baare et al., "Virucidal effect of glycerol as used in donor skin preservation," Burns 20(1), S77-S88 (1994).
6. J. Van Bueren, D.P. Larkin, and R.A. Simpson, "Inactivation of human immunodeficiency virus type 1 by alcohols," J. Hosp. Infect. 28(2), 137-148 (1994).
7. J.M. Jamison et al., "Potentiation of the antiviral activity of poly r(A-U) by xanthene dyes," Cell Biol. Int. Rep. 14(12), 1075-1084 (1990).
8. H.J. Eggers, "Experiments on antiviral activity of hand disinfectants: Some theoretical and practical considerations," Zentralbl. Bakteriol. 273(1), 36-51 (1990).
9. S.J. Withrow et al., "Evaluation of the antiretroviral effect of various methods of sterilizing/preserving corticocancellous bone," Orthopaedic Res. Soc. 76A, 1032-1035 (1990).
10. B.M. Fideler et al., "Effects of gamma irradiation on the human immunodeficiency virus: A study in frozen human bone-patellar ligament-bone grafts obtained from infected cadavers," J. Bone Joint Surg. Am. 76(7), 1032-1035 (1994).
11. M. Salai et al., "Human immunodeficiency virus (HIV) inactivation of banked bone by gamma irradiation," Ann. Transplant. 2(1), 55-56 (1997).
12. D.G. Campbell and P. Li "Sterilization of HIV with irradiation: Relevance to infected bone allografts," Aust. NZ J. Surg. 69(7), 517-521 (1999).
13. J.T. Mellonig, A.B. Prewett, and M.P. Moyer, "HIV inactivation in a bone allograft," J. Periodontol. 63(12), 979-983 (1992).
14. J.T. Mellonig, "Donor selection, testing, and inactivation of the HIV virus in freeze-dried bone allografts," Pract. Periodontics Aesthet. Dent. 7(6), 13-22, Quiz 23 (1995).
15. N.L. Scarborough et al., "Allograft safety: Viral inactivation with bone demineralization," Contemp. Orthop. 31(4), 257-261 (1995).
16. J. Fages et al., "Viral inactivation of human bone tissue using supercritical fluid extraction," ASAIO J. 44(4), 289-293 (1998).
17. F.C. Krebs et al., "Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate," Antiviral Res. 43(3), 157-173 (1999).
18. J. North et al., "Photodynamic inactivation of retrovirus by benzoporphyrin derivative: A feline leukemia virus model," Transfusion 32(2), 121-128 (1992).
19. S.B. Tang and J.A. Levy, "Inactivation of HIV-1 by trypsin and its use in demonstrating specific virus infection of cells," J. Virol. Methods 33(1-2), 39-46 (1991).
20. J.B. Hudson, I. Lopez-Bazzocchi, and G.H.N. Towers, "Antiviral activities of hypericin," Antiviral Res. 15, 101-112 (1991).
21. E.G. Hulskotte et al., "Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins," Vaccine 15(17-18), 1839-1845 (1997).
22. G. Karupiah and N. Harris, "Inhibition of viral replication by nitric oxide and its reversal by ferrous sulfate and tricarboxylic acid cycle metabolites," J. Exp. Med. 181(6), 2171-2179 (1995).
23. C.H. Aloisio and J.K. Nicholson, "Recovery of infectious human immunodeficiency virus from cells treated with 1% paraformaldehyde," J. Immunol. Methods 128(2), 281-285 (1990).
24. A.J. Watson, J. Klaniecki, and C.V. Hanson, "Psoralen/UV inactivation of HIV-1-Infected cells for use in cytologic and immunologic procedures," AIDS Res. Hum. Retroviruses 6(4), 503-513 (1990).
25. J. Bestman-Smith et al., "Sodium lauryl sulfate abrogates human immunodeficiency virus infectivity by affecting viral attachment," Antimicrob. agents Chemother. 45(8), 2229-2237 (2001).